The first step in the management of VAD thrombosis is establishing the diagnosis. The diagnosis of pump thrombosis can be challenging, requiring a high degree of vigilance. In a recently published case series, our group described for the first time that VAD thrombosis is a spectrum of clinical presentations with a broad range of signs and symptoms (6) . On one side of the spectrum, patients may be completely asymptomatic with no change in their functional capacity, with signs of hemolysis as the only manifestation (6) . Other more common presentations include exacerbating heart failure symptoms, new thromboembolic event, syncope, and cardiogenic shock (6).
To detect patients in early stages of device thrombosis, it is crucial to monitor the plasma markers of hemolysis, such as lactate dehydrogenase (LDH) levels and plasma-free hemoglobin. Uriel et al. (7) reported that an LDH level more than 5 times the normal limit is highly specific (92.5%) and sensitive (100%) for the diagnosis. In our series, 2 patients with confirmed pump thrombosis had a <3-fold increase in LDH, reducing the sensitivity of 5-fold LDH cutoff to 82% (6) . Thus, in patients with normal LDH levels, other causes of the symptoms/signs of recurrent heart failure should be considered, such as aortic insufficiency and right ventricular failure.
In HeartMate II patients, the next step in the diagnosis in hemodynamically stable patients with suspected VAD thrombosis is the echocardiographic ramp study. In this study, repeat echocardiographic measurements are recorded at different pump speed, comparing changes in various parameters (e.g., left ventricular end-diastolic diameter, power of the device, frequency of aortic valve opening, mitral valve regurgitation). This study has high sensitivity and specificity in HeartMate II patients when used in conjunction with LDH levels (7). However, the utility and safety of using the echocardiographic ramp study in HVAD patients has not been demonstrated in the setting of HVAD thrombosis.
The recommended treatment of HeartMate II VAD thrombosis is pump replacement or heart transplant. Rame and Birati 
